RecruitingNot ApplicableNCT05759806
Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF
Sponsor
Nephronyx LTD
Enrollment
10 participants
Start Date
Dec 19, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this interventional study is to evaluate the safety and functional performance of the Nephronyx System in patients with ADHF, presenting clinical signs of volume overload and compromised response to diuretics.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is evaluating a new medical device called the Nephronyx System in people who are hospitalized with acute decompensated heart failure (ADHF) — a condition where the heart suddenly becomes unable to pump blood properly, causing dangerous fluid buildup — and whose kidneys are not responding well to diuretic (water pill) medications.
**You may be eligible if...**
- You are admitted to hospital primarily because of severe heart failure
- You have visible signs of excess fluid in your body
- Your heart pumping function is above 15%
- Your kidneys are not responding adequately to diuretics (water pills)
- Your blood marker for heart stress (NT-proBNP or BNP) is elevated
**You may NOT be eligible if...**
- You have a blood clot in your leg veins (DVT) or history of DVT
- You have a narrowing of the arteries supplying your kidneys
- Your BMI is above 35
- You have untreated abnormal heart rhythms or recent heart procedures
- You have severe kidney disease requiring dialysis
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICENephronyx system (Perfuser)
Temporary deployment of the Nephronyx system (Perfuser)
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05759806
Related Trials
Reprieve System Pilot Study
NCT062727341 location
Add-on Diuretics in Acute Decompensated Heart Failure
NCT073720401 location
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
NCT0689851553 locations
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
NCT071990881 location
EACH-ADHF: Early Comprehensive Rehabilitation in Patients With ADHF
NCT061619871 location